- May 31, 2021

Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier.
Vitamin K2 is an essential nutrient for optimal bone and cardiovascular health, but the modern diet does not include sufficient quantities of it. Only a few foods are naturally high in vitamin K2, such as natto, a Japanese fermented soybean dish, and these are not a mainstream part of diets in the United States or elsewhere. As a result, supplementation is necessary.
Gnosis by Lesaffre’s vitaMK7® and NattoPharma’s MenaQ7® solutions have been a part of formulations for nutraceutical and functional food products for over 10 years. This acquisition allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.
With the acquisition, the two players are coming together to expand their capabilities, their global reach, and to fuel future innovation as demand for vitamin K2 grows.
DISCOVER ALL OUR LATEST NEWS

Support Longevity with the Premium Quality Methylator Agent: Exclusive Interview with Prof. Fuso, Ph.D
What is epigenetics, and what is its link to methylation?

New Study Highlights Impact of Proactive Bone Health Strategies
New research shows increasing bone mineral density by 3% equates

Highlights from Supply Side West 2023: Unveiling MenaQ7® Protect
This year’s SupplySide West set the stage for our first-of-its-kind,